Found: 55
Select item for more details and to access through your institution.
Nelarabine.
- Published in:
- Nature Reviews Drug Discovery, 2006, v. 5, n. 1, p. 17, doi. 10.1038/nrd1933
- By:
- Publication type:
- Article
Relationship Between Hip and Knee Strength and Knee Valgus During a Single Leg Squat.
- Published in:
- Journal of Applied Biomechanics, 2006, v. 22, n. 1, p. 41, doi. 10.1123/jab.22.1.41
- By:
- Publication type:
- Article
Targeting MCL-1 protein to treat cancer: opportunities and challenges.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1226289
- By:
- Publication type:
- Article
Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1161254
- By:
- Publication type:
- Article
Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapy.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 2, p. 266, doi. 10.1111/bjh.14859
- By:
- Publication type:
- Article
8-Chloroadenosine Sensitivity in Renal Cell Carcinoma Is Associated with AMPK Activation and mTOR Pathway Inhibition.
- Published in:
- PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0135962
- By:
- Publication type:
- Article
Integrative Gene Expression Profiling Reveals G6PD-Mediated Resistance to RNA-Directed Nucleoside Analogues in B-Cell Neoplasms.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041455
- By:
- Publication type:
- Article
Defective Molecular Timer in the Absence of Nucleotides Leads to Inefficient Caspase Activation.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0016379
- By:
- Publication type:
- Article
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
hTERT associates with human telomeres and enhances genomic stability and DNA repair.
- Published in:
- Oncogene, 2003, v. 22, n. 1, p. 131, doi. 10.1038/sj.onc.1206063
- By:
- Publication type:
- Article
Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid Metabolism.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1446, doi. 10.3390/cancers14061446
- By:
- Publication type:
- Article
Complete hematologic and cytogenetic response to 2-amino-9-β-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogeneous leukemia in T-cell blastic phase.
- Published in:
- Cancer (0008543X), 1999, v. 85, n. 1, p. 58, doi. 10.1002/(SICI)1097-0142(19990101)85:1<58::AID-CNCR8>3.0.CO;2-E
- By:
- Publication type:
- Article
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Correction to: Activation of ATM kinase by ROS generated during ionophore‑induced mitophagy in human T and B cell malignancies.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Activation of ATM kinase by ROS generated during ionophore-induced mitophagy in human T and B cell malignancies.
- Published in:
- Molecular & Cellular Biochemistry, 2021, v. 476, n. 1, p. 417, doi. 10.1007/s11010-020-03917-1
- By:
- Publication type:
- Article
Bcl-2 antagonists: a proof of concept for CLL therapy.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1384, doi. 10.1007/s10637-013-0002-4
- By:
- Publication type:
- Article
A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 121, n. 2, p. 355, doi. 10.1007/s10549-009-0481-3
- By:
- Publication type:
- Article
Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.833714
- By:
- Publication type:
- Article
Phase I and extension study of clofarabine plus cyclophosphamide in patients with relapsed/refractory acute lymphoblastic leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Biological effects of the Pim kinase inhibitor, SGI-1776, in multiple myeloma.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Preclinical and Clinical Evaluation of Forodesine in Pediatric and Adult B-Cell Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 458, doi. 10.1016/j.clml.2013.04.009
- By:
- Publication type:
- Article
Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
2‐Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 3, p. 541, doi. 10.1002/cncr.21186
- By:
- Publication type:
- Article
The role of clofarabine in hematologic and solid malignancies—Development of a next‐generation nucleoside analog.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 10, p. 1985
- By:
- Publication type:
- Article
A systematic review exploring the evidence reported to underpin exercise dose in clinical trials of rheumatoid arthritis.
- Published in:
- Rheumatology, 2020, v. 59, n. 11, p. 3147, doi. 10.1093/rheumatology/keaa150
- By:
- Publication type:
- Article
Ibrutinib, Fludarabine, Cyclophosphamide, and Obinutuzumab (GA101) (iFCG) Treatment for First-Line Therapy of Patients with CLL with Mutated IGHV and Without Deletion 17p.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S13, doi. 10.1016/j.clml.2017.09.041
- By:
- Publication type:
- Article
Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeting MET transcription as a therapeutic strategy in multiple myeloma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 4, p. 587, doi. 10.1007/s00280-008-0770-2
- By:
- Publication type:
- Article
Biochemical modulation of cytarabine triphosphate by clofarabine.
- Published in:
- 2005
- By:
- Publication type:
- journal article
In vitro assessment of nucleoside analogs in multiple myeloma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 2, p. 113, doi. 10.1007/s00280-004-0777-2
- By:
- Publication type:
- Article
Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 2, p. 85, doi. 10.1007/s00280-002-0456-0
- By:
- Publication type:
- Article
Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug.
- Published in:
- International Journal of Oncology, 2015, v. 47, n. 2, p. 782, doi. 10.3892/ijo.2015.3037
- By:
- Publication type:
- Article
Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00675-9
- By:
- Publication type:
- Article
Ibrutinib combinations in CLL therapy: scientific rationale and clinical results.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 4, p. 1, doi. 10.1038/s41408-021-00467-7
- By:
- Publication type:
- Article
Cellular and clinical pharmacology of fludarabine.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Clofarabine, a Second-Generation Nucleoside Analog, in Pediatric Patients With Acute Leukemia.
- Published in:
- Journal of Clinical Pharmacology, 2004, v. 44, n. 11, p. 1309, doi. 10.1177/0091270004269236
- By:
- Publication type:
- Article
Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture (PROVE): study protocol for a randomised controlled trial.
- Published in:
- Trials, 2014, v. 15, n. 1, p. 1, doi. 10.1186/1745-6215-15-22
- By:
- Publication type:
- Article
Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture (PROVE): study protocol for a randomised controlled trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 3, doi. 10.1186/1756-8722-6-92
- By:
- Publication type:
- Article
Non-contact health monitoring to support care in a psychiatric intensive care unit.
- Published in:
- Journal of Psychiatric Intensive Care, 2022, v. 18, n. 2, p. 95, doi. 10.20299/jpi.2022.008
- By:
- Publication type:
- Article
A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 3, p. 722, doi. 10.1002/cncr.26327
- By:
- Publication type:
- Article
Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 3, p. 297, doi. 10.1111/j.1365-2141.2009.07850.x
- By:
- Publication type:
- Article
Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene ( NR3C1).
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 6, p. 856, doi. 10.1111/j.1365-2141.2008.07549.x
- By:
- Publication type:
- Article
HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.
- Published in:
- British Journal of Haematology, 2008, v. 142, n. 4, p. 551, doi. 10.1111/j.1365-2141.2008.07217.x
- By:
- Publication type:
- Article
RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells.
- Published in:
- British Journal of Haematology, 2008, v. 140, n. 6, p. 682, doi. 10.1111/j.1365-2141.2007.06955.x
- By:
- Publication type:
- Article
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Acta Haematologica, 2018, v. 140, n. 1, p. 30, doi. 10.1159/000490092
- By:
- Publication type:
- Article
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01076-4
- By:
- Publication type:
- Article